Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Daily berries and cocoa enhance mood by targeting key brain pathways

17

Nov 2025

Daily berries and cocoa enhance mood by targeting key brain pathways

Dietary flavonoids from everyday foods show modest but promising benefits for mood, with the strongest evidence emerging from chronic, anthocyanin rich interventions. Acute effects are mixed, but longer term intake may support emotional well being through mechanisms involving monoamine activity and neuroplasticity.

Maternal obesity raises childhood epilepsy and disability risks, new study shows

17

Nov 2025

Maternal obesity raises childhood epilepsy and disability risks, new study shows

Higher maternal BMI before pregnancy is linked to increased risks of epilepsy and intellectual disability in young children, even after extensive adjustment for maternal and neonatal factors. Associations with autism spectrum disorder and ADHD disappear after full adjustment, highlighting the potential mediating role of perinatal complications.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.